Diabetes mellitus has become a global epidemic. As reported by the WHO, the number of patients with this disease has increased 4-fold over the last 30 years. Nowadays, 422 million people worldwide are suffering from this disease. Diabetes is one of the main causes of blindness, kidney failure, heart attacks, strokes and amputations of the lower extremities. Scientists predict that diabetes will be the 7th cause of death in the world by 2030. Besides a family history, an important cause of diabetes is excess weight associated with an unhealthy lifestyle.
Diabetes is dangerous, mainly because of its complications that affect the vascular and nervous systems. Therefore, it is very important to use natural treatments that not only lower the blood glucose levels but also prevent the complications of diabetes.
In 2017, Nutrimed launched the manufacture of a new natural complex that produces a maximal effect on the key links of diabetes pathogenesis – GLUCEMEDIN®. GLUCEMEDIN® contains the standardized extracts of gymnema leaves (Gymnema Sylvestre), banaba leaves (Lagerstroemia speciose) and bitter melon (Momordica charantia). GLUCEMEDIN® lowers the blood glucose levels, improves lipid metabolism, and reduces the body weight in diabetic patients.
Moreover, GLUCEMEDIN® lowers the risk of vascular and infectious complications of diabetes.
Furthermore, for almost 10 years, Nutrimed has been manufacturing a unique herbal medication – INULIN-NUTRIMED®.
INULIN-NUTRIMED® is produced under an in-house patented technology from fresh chicory roots (Cichorium intybus), and its primary active ingredient is a high molecular weight polysaccharide inulin.
